Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Medicinal Chemistry|March 10, 2007
DNA repair helicases as targets for anti-cancer therapyRigu Gupta, Robert M Brosh
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
Helicases as prospective targets for anti-cancer therapyRigu Gupta, Robert M Brosh
Anti-Cancer Agents in Medicinal Chemistry|May 14, 2008
BRCA-FA pathway as a target for anti-tumor drugsRachel Litman, Rigu Gupta, Robert M Brosh, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Tetraplex binding molecules as anti-cancer agentsKevin M Doherty, Sudha Sharma, Rigu Gupta, et al.
The Journal of Biological Chemistry|May 10, 2005
Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancerRigu Gupta, Sudha Sharma, Joshua A Sommers, et al.
Nucleic Acids Research|December 6, 2006
Inhibition of BACH1 (FANCJ) helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strandRigu Gupta, Sudha Sharma, Kevin M Doherty, et al.
Blood|June 29, 2007
FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding proteinRigu Gupta, Sudha Sharma, Joshua A Sommers, et al.
Oncotarget|March 8, 2011
FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancerFrancesca Scrimieri, Eric S Calhoun, Kalpesh Patel, et al.
The Journal of Biological Chemistry|January 20, 2009
FANCJ uses its motor ATPase to destabilize protein-DNA complexes, unwind triplexes, and inhibit RAD51 strand exchangeJoshua A Sommers, Nina Rawtani, Rigu Gupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 16, 2012
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioningKakali Sarkar, Zheqing Cai, Rigu Gupta, et al.
Pageof 1